Emine Ahu Koç

Emine Ahu Koç

Auto-generated profile, based on publicly available information

Emine Ahu Koç

Department of Obstetrics and Gynecology, Giresun University, Giresun, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Istanbul Medical Journal
Verified
Journal Article
Closed access
MÖMiraç Özalp
Miraç Özalp
HŞHidayet şal
Hidayet şal
EKEmine Ahu Koç
Emine Ahu Koç
HAHümeyra Akbaş
Hümeyra Akbaş
ODOmer Demir
Omer Demir
MOMehmet Armağan Osmanağaoğlu
Mehmet Armağan Osmanağaoğlu

1 September 2018 in Reproductive Toxicology
Verified
Journal Article
Closed access
NKNuri I. Kalyoncu
Nuri I. Kalyoncu
LCLrem Cavusoglu
Lrem Cavusoglu
LELlknur Erkoseoglu
Llknur Erkoseoglu
MKMine Kadioglu
Mine Kadioglu
TATurhan Aran
Turhan Aran
EYErsin Yaris
Ersin Yaris

1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
ODOmer Demir
Omer Demir
GOGülsün Ozbay
Gülsün Ozbay
MOMirac Ozalp
Mirac Ozalp
HŞHidayet şal
Hidayet şal
GKGokce Omeroglu Kayıkcı
Gokce Omeroglu Kayıkcı
MOMehmet Armagan Osmanagaoglu
Mehmet Armagan Osmanagaoglu
OBJECTIVE: In this study, an investigation was undertaken to determine whether the well-being of the fetus is affected in pregnant women who have a severe fear of childbirth.

24 September 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
SSSercan Serin
Sercan Serin
EKEmine Ahu Koç
Emine Ahu Koç
SASakine Merve Aydın
Sakine Merve Aydın
GÜGökhan Ünver
Gökhan Ünver
BABahattin Avcı
Bahattin Avcı

16 September 2026 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
EKEmine Ahu Koc
Emine Ahu Koc
ZYZehra Yılmaz
Zehra Yılmaz
SCSamettin Celik
Samettin Celik
SASakine Merve Aydın
Sakine Merve Aydın
MAMevlude Alpaslan Arar
Mevlude Alpaslan Arar
NGNeset Gumusburun
Neset Gumusburun
Background: Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and neonatal outcomes. The identification of novel biomarkers for GDM remains an important clinical objective. The aim of this study was to investigate whether maternal serum periostin levels measured between 24 and 28 weeks of gestation could serve as a biomarker for the diagnosis of GDM and to evaluate their association with maternal and neonatal outcomes. Methods: This case-control study was conducted at Samsun Training and Research Hospital between January 2024 and February 2025. Serum periostin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: Serum periostin levels were significantly higher in the GDM group than in the control group (101.4 (53.6) vs. 34.6 (23.9) ng/mL, p < 0.001). Correlation analysis revealed that serum periostin levels were positively correlated with fasting glucose (r = 0.453, p < 0.001), 1-hour oral glucose tolerance test (OGTT) (r = 0.525, p < 0.001), 2-hour OGTT (r = 0.481, p < 0.001), maternal body mass index (BMI) (r = 0.750, p < 0.001), and fetal birth weight (r = 0.351, p < 0.001). Receiver operating characteristic (ROC) curve analysis demonstrated excellent diagnostic performance for serum periostin (area under the curve [AUC] = 0.932, 95% confidence interval [CI]: 0.899–0.966, p < 0.001). The multivariable model showed even higher diagnostic accuracy (AUC = 0.976, 95% CI: 0.957–0.994, p < 0.001). Conclusions: Maternal serum periostin levels are significantly associated with the presence of GDM and adverse perinatal outcomes. These findings suggest that periostin may represent a potentially useful biomarker associated with GDM; however, its role in screening or prediction requires further prospective validation.